Inhibition of TRF2 Leads to Ferroptosis, Autophagic Death, and Apoptosis by Causing Telomere Dysfunction

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2023 Apr 28

PMID 37113742

Authors

Qiuhui Yang

Ziyang Nie

Yukun Zhu

Mingying Hao

Siqi Liu

Xuelu Ding

Feng Wang

Fei Wang

Xin Geng

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer (GC) is an aggressive malignancy with a high mortality rate and poor prognosis. Telomeric repeat-binding factor 2 (TRF2) is a critical telomere protection protein. Emerging evidence indicates that TRF2 may be an essential treatment option for GC; however, the exact mechanism remains largely unknown.

Objective: We aimed to explore the role of TRF2 in GC cells. The function and molecular mechanisms of TRF2 in the pathogenesis of GC were mainly discussed in this study.

Methods: Relevant data from GEPIA and TCGA databases regarding TRF2 gene expression and its prognostic significance in GC samples were analyzed. Analysis of 53BP1 foci at telomeres by immunofluorescence, metaphase spreads, and telomere-specific FISH analysis was carried out to explore telomere damage and dysfunction after TRF2 depletion. CCK8 cell proliferation, trypan blue staining, and colony formation assay were performed to evaluate cell survival. Apoptosis and cell migration were determined with flow cytometry and scratch-wound healing assay, respectively. qRT-PCR and Western blotting were carried out to analyze the mRNA and protein expression levels after TRF2 depletion on apoptosis, autophagic death, and ferroptosis.

Results: By searching with GEPIA and TCGA databases, the results showed that the expression levels of TRF2 were obviously elevated in the samples of GC patients, which was associated with adverse prognosis. Knockdown of TRF2 suppressed the cell growth, proliferation, and migration in GC cells, causing significant telomere dysfunction. Apoptosis, autophagic death, and ferroptosis were also triggered in this process. The pretreatment of chloroquine (autophagy inhibitor) and ferrostatin-1 (ferroptosis inhibitor) improved the survival phenotypes of GC cells.

Conclusion: Our data suggest that TRF2 depletion can inhibit cell growth, proliferation, and migration through the combined action of ferroptosis, autophagic death, and apoptosis in GC cells. The results indicate that TRF2 might be used as a potential target to develop therapeutic strategies for treating GC.

Citing Articles

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.

PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.

Ferroptosis and its role in gastric and colorectal cancers.

Hou J, Wang B, Li J, Liu W Korean J Physiol Pharmacol. 2024; 28(3):183-196.

PMID: 38682167 PMC: 11058540. DOI: 10.4196/kjpp.2024.28.3.183.

miR-29b-1-5p exacerbates myocardial injury induced by sepsis in a mouse model by targeting TERF2.

Jiang Y, Xu J, Zeng H, Lin Z, Yi Q, Guo J Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):607-620.

PMID: 38414350 PMC: 11090849. DOI: 10.3724/abbs.2024020.

References

Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

Luoqian J, Yang W, Ding X, Tuo Q, Xiang Z, Zheng Z . Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis. Cell Mol Immunol. 2022; 19(8):913-924. PMC: 9338013. DOI: 10.1038/s41423-022-00883-0. View

Wang Y, Lu J, Wang F, Wang Y, He M, Wu Q . Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Cancer Lett. 2020; 473:74-89. DOI: 10.1016/j.canlet.2019.12.036. View

Stockwell B, Jiang X, Gu W . Emerging Mechanisms and Disease Relevance of Ferroptosis. Trends Cell Biol. 2020; 30(6):478-490. PMC: 7230071. DOI: 10.1016/j.tcb.2020.02.009. View

Zlotorynski E . Telomere crisis activates autophagic death. Nat Rev Mol Cell Biol. 2019; 20(3):133. DOI: 10.1038/s41580-019-0105-7. View

Anding A, Baehrecke E . Cleaning House: Selective Autophagy of Organelles. Dev Cell. 2017; 41(1):10-22. PMC: 5395098. DOI: 10.1016/j.devcel.2017.02.016. View

Shahin V . Strategic disruption of nuclear pores structure, integrity and barrier for nuclear apoptosis. Semin Cell Dev Biol. 2017; 68:85-90. DOI: 10.1016/j.semcdb.2017.07.002. View

Imran S, Yazid M, Cui W, Lokanathan Y . The Intra- and Extra-Telomeric Role of TRF2 in the DNA Damage Response. Int J Mol Sci. 2021; 22(18). PMC: 8470803. DOI: 10.3390/ijms22189900. View

Jiang X, Yan Q, Xie L, Xu S, Jiang K, Huang J . Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer. J Oncol. 2021; 2021:6635526. PMC: 7937463. DOI: 10.1155/2021/6635526. View

10.

Mathew R, Karantza-Wadsworth V, White E . Role of autophagy in cancer. Nat Rev Cancer. 2007; 7(12):961-7. PMC: 2866167. DOI: 10.1038/nrc2254. View

11.

Bellon M, Datta A, Brown M, Pouliquen J, Couppie P, Kazanji M . Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia. Int J Cancer. 2006; 119(9):2090-7. DOI: 10.1002/ijc.22026. View

12.

Bollschweiler E, Berlth F, Baltin C, Monig S, Holscher A . Treatment of early gastric cancer in the Western World. World J Gastroenterol. 2014; 20(19):5672-8. PMC: 4024776. DOI: 10.3748/wjg.v20.i19.5672. View

13.

Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G . Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2. Biochim Biophys Acta Gen Subj. 2017; 1861(12):3246-3256. DOI: 10.1016/j.bbagen.2017.09.015. View

14.

Wang Y, Zhang L, Yang Y, Lu S, Chen H . Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int J Biol Sci. 2021; 17(4):1041-1049. PMC: 8040314. DOI: 10.7150/ijbs.56735. View

15.

Zhou W, Deng R, Zhang X, Feng G, Gu L, Zhu X . G-quadruplex ligand SYUIQ-5 induces autophagy by telomere damage and TRF2 delocalization in cancer cells. Mol Cancer Ther. 2009; 8(12):3203-13. DOI: 10.1158/1535-7163.MCT-09-0244. View

16.

Lazzerini-Denchi E, Sfeir A . Stop pulling my strings - what telomeres taught us about the DNA damage response. Nat Rev Mol Cell Biol. 2016; 17(6):364-78. PMC: 5385261. DOI: 10.1038/nrm.2016.43. View

17.

Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv H . Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 2020; 483:127-136. DOI: 10.1016/j.canlet.2020.02.015. View

18.

Sahin E, Colla S, Liesa M, Moslehi J, Muller F, Guo M . Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011; 470(7334):359-65. PMC: 3741661. DOI: 10.1038/nature09787. View

19.

Guan Z, Chen J, Li X, Dong N . Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep. 2020; 40(8). PMC: 7953492. DOI: 10.1042/BSR20201807. View

20.

Smogorzewska A, de Lange T . Different telomere damage signaling pathways in human and mouse cells. EMBO J. 2002; 21(16):4338-48. PMC: 126171. DOI: 10.1093/emboj/cdf433. View